Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC pharmacological fMRI study in ADHD
NL-OMON35106Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of dronabinol in attention deficit hyperactivity disorder (ADHD), sponsored by University Medical Center Utrecht. Primary endpoint: BOLD signal on fMRI. Planned start Jun 2010; status: withdrawn.
02
Drugs
dronabinol
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON35106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35106.